These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27109558)

  • 1. Increasing Patient Acceptance and Adherence Toward Insulin.
    Riddle M; Peters A; Funnell M
    Postgrad Med; 2016 Oct; 128 Suppl 1():11-20. PubMed ID: 27109558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of postprandial glycemic control: optimizing add-on therapy to basal insulin.
    Shaefer CF; Anderson J
    Postgrad Med; 2016 Jan; 128(1):137-44. PubMed ID: 26548422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.
    Rakel RE
    Adv Ther; 2009 Sep; 26(9):838-46. PubMed ID: 19768641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.
    Marrero DG
    Clin Cornerstone; 2008; 9(2):63-70; discussion 71-3. PubMed ID: 19410163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do health care professionals assess patients when initiating insulin therapy? A qualitative study.
    Lee PY; Lee YK; Khoo EM; Ng CJ
    Prim Care Diabetes; 2014 Apr; 8(1):49-55. PubMed ID: 24315732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges associated with insulin therapy in type 2 diabetes mellitus.
    Edelman S; Pettus J
    Am J Med; 2014 Oct; 127(10 Suppl):S11-6. PubMed ID: 25282008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying and addressing barriers to insulin acceptance and adherence in patients with type 2 diabetes mellitus.
    Petznick AM
    J Am Osteopath Assoc; 2013 Apr; 113(4 Suppl 2):S6-16. PubMed ID: 23545891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why and how to use insulin therapy earlier in the management of type 2 diabetes.
    Meneghini L
    South Med J; 2007 Feb; 100(2):164-74. PubMed ID: 17330687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current barriers to initiating insulin therapy in individuals with type 2 diabetes.
    Galdón Sanz-Pastor A; Justel Enríquez A; Sánchez Bao A; Ampudia-Blasco FJ
    Front Endocrinol (Lausanne); 2024; 15():1366368. PubMed ID: 38559691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The introduction of insulin in type 2 diabetes mellitus.
    Wong J; Tabet E
    Aust Fam Physician; 2015 May; 44(5):278-83. PubMed ID: 26042399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiating insulin in primary care--the role of modern premixed formulations.
    Ligthelm R; Davidson J
    Prim Care Diabetes; 2008 Feb; 2(1):9-16. PubMed ID: 18684415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.
    Marrero DG
    Clin Cornerstone; 2007; 8(2):33-40; discussion 41-3. PubMed ID: 18357954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standards of care and the burden of treatment failure in type 2 diabetes.
    Urquhart BS
    JAAPA; 2007 Oct; Suppl Initiating Insulin():3-8. PubMed ID: 18050526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes.
    Ahmann A; Szeinbach SL; Gill J; Traylor L; Garg SK
    Diabetes Technol Ther; 2014 Feb; 16(2):76-83. PubMed ID: 24266497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of timely basal insulin control in patients with type 2 diabetes.
    Lovre D; Fonseca V
    J Diabetes Complications; 2015 Mar; 29(2):295-301. PubMed ID: 25536866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
    Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
    Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts in diabetes: how multihormonal regulation can improve glycemic control.
    Blonde L; Baker DE; Davis SN; Ratner RE
    J Manag Care Pharm; 2004 Dec; 10(6 Suppl B):S3-8; quiz S9, S11-2. PubMed ID: 23570175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in insulin therapy for type 2 diabetes.
    Sorli C
    Am J Med; 2014 Oct; 127(10 Suppl):S39-48. PubMed ID: 25282012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating insulin in patients with type 2 diabetes.
    Aoki TJ; White RD
    J Fam Pract; 2007 Aug; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.